Literature DB >> 25411054

Increased plasma DPP4 activity predicts new-onset hypertension in Chinese over a 4-year period: possible associations with inflammation and oxidative stress.

T Zheng1, T Chen2, Y Liu3, Y Gao2, H Tian2.   

Abstract

To investigate whether increased dipeptidyl peptidase 4 (DPP4) activity predicts new-onset hypertension in Chinese patients. A prospective study was conducted for 1884 adults (804 men/1080 women) aged 18-70 years without hypertension. Participants were examined in 2007 (baseline) and 2011 (follow-up) and circulating DPP4 activity, mannose 6-phosphate receptor (M6P-R) concentration, inflammatory markers and oxidative stress parameters were measured. After a 4-year follow-up, 296 individuals developed hypertension with an incidence of 39 per 1000 patient years. In multiple linear regression analyses, baseline DPP4 activity was an independent predictor of an increase in M6P-R, inflammatory markers and oxidative stress parameters over a 4-year period (all P < 0.01). Cox proportional hazards models revealed that DPP4 activity independently predicted the risk of developing hypertension (relative risk 2.68 (95% confidence interval 1.71-4.21) P < 0.01). Our results indicate that DPP4 activity is an important predictor of hypertension onset in apparently healthy Chinese individuals. This finding may have important implications for understanding the effects of DPP4 in promoting inflammation and oxidative stress in the pathogenesis of hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25411054     DOI: 10.1038/jhh.2014.111

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  24 in total

1.  Prevalence of diabetes among men and women in China.

Authors:  Wenying Yang; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Guangliang Shan; Jiang He
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 2.  Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

Authors:  G Zalba; G San José; M U Moreno; M A Fortuño; A Fortuño; F J Beaumont; J Díez
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

Review 3.  Impact of inflammation on vascular disease in hypertension.

Authors:  Agostino Virdis; Umberto Dell'Agnello; Stefano Taddei
Journal:  Maturitas       Date:  2014-04-24       Impact factor: 4.342

4.  Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes.

Authors:  Nilani Jeyaratnaganthan; Kurt Højlund; Jens Peter Kroustrup; Jens Fromholt Larsen; Mette Bjerre; Klavs Levin; Henning Beck-Nielsen; Susana Frago; A Bassim Hassan; Allan Flyvbjerg; Jan Frystyk
Journal:  Growth Horm IGF Res       Date:  2010-01-27       Impact factor: 2.372

5.  Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.

Authors:  R Preston Mason; Robert F Jacob; Ruslan Kubant; Aleksander Ciszewski; J Jose Corbalan; Tadeusz Malinski
Journal:  J Cardiovasc Pharmacol       Date:  2012-11       Impact factor: 3.105

6.  Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes.

Authors:  O J Cordero; F J Salgado; J E Viñuela; M Nogueira
Journal:  Immunobiology       Date:  1997-11       Impact factor: 3.144

Review 7.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 8.  Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme.

Authors:  E Matteucci; O Giampietro
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.

Authors:  Daniela Lamers; Susanne Famulla; Nina Wronkowitz; Sonja Hartwig; Stefan Lehr; D Margriet Ouwens; Kristin Eckardt; Jean M Kaufman; Mikael Ryden; Stefan Müller; Franz-Georg Hanisch; Johannes Ruige; Peter Arner; Henrike Sell; Juergen Eckel
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

10.  Prevalence of hypertension in china: a cross-sectional study.

Authors:  Yun Gao; Gang Chen; Haoming Tian; Lixiang Lin; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhiguang Zhou; Xingwu Ran; Yan Ren; Tao Chen; Wenying Yang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more
  7 in total

1.  The Association Between Circulating Klotho and Dipeptidyl Peptidase-4 Activity and Inflammatory Cytokines in Elderly Patients With Alzheimer Disease.

Authors:  Mohsen Sedighi; Tourandokht Baluchnejadmojarad; Soudabeh Fallah; Nariman Moradi; Siamak Afshin-Majd; Mehrdad Roghani
Journal:  Basic Clin Neurosci       Date:  2020-05-01

2.  Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.

Authors:  Radwan H Ahmed; Hasniza Zaman Huri; Zaid Al-Hamodi; Sameer D Salem; Sekaran Muniandy
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

3.  Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.

Authors:  Bo Chen; Tianpeng Zheng; Linyuan Qin; Xueping Hu; Xiaoxi Zhang; Yihong Liu; Hongbo Liu; Shenghua Qin; Gang Li; Qinghua Li
Journal:  Front Aging Neurosci       Date:  2017-07-26       Impact factor: 5.750

4.  Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.

Authors:  Jing-Wei Li; Yun-Dai Chen; Wei-Ren Chen; Qi You; Bo Li; Hao Zhou; Ying Zhang; Tian-Wen Han
Journal:  Cardiovasc Diabetol       Date:  2017-06-06       Impact factor: 9.951

5.  Molecular Changes in Circulating microRNAs' Expression and Oxidative Stress in Adults with Mild Cognitive Impairment: A Biochemical and Molecular Study.

Authors:  Hadeel A Al-Rawaf; Ahmad H Alghadir; Sami A Gabr
Journal:  Clin Interv Aging       Date:  2021-01-08       Impact factor: 4.458

6.  Association of the rs17574 DPP4 Polymorphism with Premature Coronary Artery Disease in Diabetic Patients: Results from the Cohort of the GEA Mexican Study.

Authors:  Gilberto Vargas-Alarcón; Maria Del Carmen González-Salazar; Adrian Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Julian Ramírez-Bello; José Manuel Rodríguez-Pérez; Rosalinda Posadas-Sánchez
Journal:  Diagnostics (Basel)       Date:  2022-07-15

7.  The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.

Authors:  Gilberto Vargas-Alarcón; María Del Carmen González-Salazar; Christian Vázquez-Vázquez; Adrián Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Juan Reyes-Barrera; Sergio A Criales-Vera; Marco Sánchez-Guerra; Citlalli Osorio-Yáñez; Rosalinda Posadas-Sánchez
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.